marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q2
added 08-08-2023
Eagle Pharmaceuticals Cash Flow 2011-2024 | EGRX
Annual Cash Flow Eagle Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
50.7 M | 28.2 M | 49.5 M | 56 M | 52.4 M | 58.9 M | 53.2 M | -9.72 M | -13.8 M | -5.88 M | -15.5 M | - |
Depreciation & Amortization |
646 K | 764 K | 872 K | 972 K | 1.16 M | 932 K | 641 K | 112 K | 104 K | 135 K | 240 K | - |
Accounts Payables |
19 M | 16.4 M | 6.27 M | 5.46 M | 9.92 M | 12 M | 14.7 M | 3.86 M | 3.5 M | - | - | - |
Accounts Receivables |
72.4 M | 41.1 M | 51.1 M | 48 M | 66.5 M | 53.8 M | 42.2 M | 26.3 M | 12 M | - | - | - |
Total Inventories |
47.8 M | 21.9 M | 8.08 M | 6.57 M | 8.3 M | 5.12 M | 2.74 M | 15 M | 1.24 M | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Eagle Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -33.5 M | - | 13.1 M | 26.4 M | -16.6 M | - | 20.1 M | 19.1 M | 10.5 M | - | 29.7 M | 24.1 M | 3.16 M | - | 59.2 M | 48.6 M | 26.2 M | - | 14.3 M | 10.6 M | 4.92 M | - | 33 M | 25.1 M | -12.4 M | - | 13.7 M | 484 K | 3.11 M | - | 7.08 M | 13.7 M | 25.8 M | -7.88 M | -13.9 M | -6.74 M | -2.07 M | 23 K | -5.56 M | -2.83 M | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
100 K | 100 K | - | 200 K | 200 K | 200 K | - | 200 K | 200 K | 200 K | - | 196 K | 209 K | 251 K | - | 241 K | 241 K | 242 K | - | 918 K | 683 K | 341 K | - | 657 K | 432 K | 196 K | - | 461 K | 296 K | 140 K | - | 31 K | 22 K | 12 K | 13 K | 73 K | 51 K | 29 K | 31 K | 105 K | 78.5 K | - | - | - | - | - | - | - | - | - |
Accounts Payables |
15.8 M | 17.1 M | 19 M | 13.2 M | 20 M | 14.5 M | 16.4 M | 12.7 M | 11.1 M | 12.6 M | 6.27 M | 6.27 M | 6.27 M | 6.27 M | 5.46 M | 5.46 M | 5.46 M | 5.46 M | 9.92 M | 9.92 M | 9.92 M | 9.92 M | 12 M | 12 M | 12 M | 12 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 3.86 M | 3.86 M | 3.86 M | 3.86 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | - | 1.19 M | 1.19 M | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
115 M | 115 M | 72.4 M | 96.9 M | 85.9 M | 131 M | 41.1 M | 45.3 M | 52.7 M | 44.9 M | 51.1 M | 50.7 M | 50.7 M | 50.7 M | 48 M | 48 M | 48 M | 48 M | 66.5 M | 66.5 M | 66.5 M | 66.5 M | 53.8 M | 53.8 M | 53.8 M | 53.8 M | 42.2 M | 42.2 M | 42.2 M | 42.2 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 12 M | 12 M | 12 M | 12 M | - | 5.12 M | 5.12 M | - | - | - | - | - | - | - | - | - |
Total Inventories |
42.5 M | 44.1 M | 47.8 M | 63.9 M | 57.7 M | 24.8 M | 21.9 M | 9.32 M | 8.29 M | 6.86 M | 8.08 M | 8.08 M | 8.08 M | 8.08 M | 6.57 M | 6.57 M | 6.57 M | 6.57 M | 8.3 M | 8.3 M | 8.3 M | 8.3 M | 5.12 M | 5.12 M | 5.12 M | 5.12 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M | 15 M | 15 M | 15 M | 15 M | 1.24 M | 1.24 M | 1.24 M | 1.24 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency